CA25 - Overview: Cancer Antigen 125 (CA 125), Serum
Evaluating individuals' response to ovarian cancer therapy Predicting recurrent ovarian cancer This test is not useful for cancer detection screening in the normal population.
C5AG - Overview: C5 Complement, Antigen, Serum
Diagnosis of C5 deficiency Investigation of a patient with an absent total complement (CH50) level
CEAPT - Overview: Carcinoembryonic Antigen (CEA), Peritoneal Fluid
An adjunct to cytology to differentiate between malignancy-related and benign causes of ascites formation
CRSY - Overview: Chromium, Synovial Fluid
Monitoring metallic prosthetic implant wear and local tissue destruction in failed hip arthroplasty constructs This test is not useful for assessment of potential chromium toxicity.
199PC - Overview: Carbohydrate Antigen 19-9 (CA 19-9), Pancreatic Cyst Fluid
As an adjunct in the assessment of pancreatic cysts, when used in conjunction with carcinoembryonic antigen, amylase, imaging studies and cytology
CEAPC - Overview: Carcinoembryonic Antigen (CEA), Pancreatic Cyst Fluid
When used in conjunction with imaging studies, cytology, and other pancreatic cyst fluid tumor markers: -Distinguishing between mucinous and nonmucinous pancreatic cysts -Determining the likely type of malignant pancreatic cyst
RSCOC - Overview: Coccidioides Antibody Reflex, Complement Fixation and Immunodiffusion, Serum
Detection of antibodies to Coccidioides species
EDN - Overview: Eosinophil Derived Neurotoxin, Serum
Evaluating patients suspected to have a condition associated with eosinophilia or hypereosinophilia Evaluating patients with elevated peripheral blood eosinophil counts Managing patients with elevated eosinophil-derived neurotoxin in the...
HYPOG - Overview: Hypoglycemic Agent Screen, Serum
Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...
Reporting an end titer result in spinal fluid specimens Distinguishing, in spinal fluid, autoimmune GFAP astrocytopathy from infectious meningoencephalitis and idiopathic inflammatory central nervous system (CNS) disorders such as multiple...
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.